Background Parkinson’s disease (PD) and Progressive Supranuclear Palsy (PSP) are neurodegenerative disorder which have Parkinsonism as core clinical feature. PD and PSP are often misdiagnosed in early phases by conventional magnetic resonance imaging (MRI). Hence the objective of the study is to evaluate accuracy of MR...
Vilhoubeinuo Veronica Khruomo, Priyanka, R. Kadavigere et al.· F1000Research· 0 citations
Reliable biomarkers for tracking Parkinson’s disease (PD) progression remain an unmet clinical need. Quantitative susceptibility mapping (QSM), an MRI technique sensitive to iron-related susceptibility changes, has emerged as a promising candidate biomarker; however, longitudinal findings have been limited and in...
Thejas M. S., S. Pendem, Arvind N. Prabhu et al.· BMC Neurology· 0 citations
It is suggested that WMH burden and disrupted white matter microstructure are associated with cognitive impairment in CSVD, and larger, standardized studies are needed to determine the clinical value of MRI markers as reliable biomarkers for early detection and monitoring of cognitive impairment in CSVD.
Babina Aryal, S. Pendem, Priya P. S. et al.· Brain Imaging and Behavior· 0 citations
An optimized low b-value-weighted acquisition with targeted averaging (A2) provided the strongest overall balance between image quality, parameter stability, tissue contrast, and correspondence with DSC-derived perfusion measures.
A. S., S. Pendem, R. Kadavigere et al.· Journal of Medical Imaging a...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.